| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.2M | -0.5% |
| Cost of Revenue | $5.4M | -6.8% |
| Gross Profit | $8.7M | +3.8% |
| R&D Expense | $906K | +3.8% |
| SG&A Expense | $7.7M | -13.9% |
| Operating Income | $6K | +100.4% |
| Pre-tax Income | $89K | +105.7% |
| Income Tax | $15K | — |
| Net Income | $74K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | -12.7% |
| Accounts Receivable | $1.8M | +19.1% |
| Inventory | $2.6M | +5.9% |
| Current Assets | $8.3M | -1.3% |
| Total Assets | $11.2M | -5.5% |
| Current Liabilities | $1.6M | -26.1% |
| Total Liabilities | $2.6M | -25.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$492K | -159.5% |
| Capital Expenditures | $55K | -26.7% |
| Investing Cash Flow | -$50K | +33.3% |
| Financing Cash Flow | -$5K | +93.7% |
| Free Cash Flow | -$547K | -172.7% |
| +104.7% |
| EPS (Basic) | $0.01 | +106.7% |
| EPS (Diluted) | $0.01 | +106.7% |
| Stockholders' Equity |
| $8.6M |
| +2.7% |